Head And Neck Cancer (Oncology) - Drugs In Development, 2021

August 2021 | 4327 pages | ID: HF3A9E0013C0EN
Global Markets Direct

Abstracts

Head And Neck Cancer (Oncology) - Drugs In Development, 2021

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Drugs In Development, 2021, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 23, 257, 225, 4, 8, 172, 42 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 14, 12, 1, 25, 4 and 1 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE

• The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
• The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

REASONS TO BUY

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contents

Introduction
Head And Neck Cancer - Overview
Head And Neck Cancer - Therapeutics Development
Head And Neck Cancer - Therapeutics Assessment
Head And Neck Cancer - Companies Involved in Therapeutics Development
Head And Neck Cancer - Drug Profiles
Head And Neck Cancer - Dormant Projects
Head And Neck Cancer - Discontinued Products
Head And Neck Cancer - Product Development Milestones
Appendix

List Of Tables

LIST OF TABLES

Number of Products under Development for Head And Neck Cancer, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Head And Neck Cancer - Pipeline by 2A Pharma AB, 2021
Head And Neck Cancer - Pipeline by 4D Pharma Plc, 2021
Head And Neck Cancer - Pipeline by 4SC AG, 2021
Head And Neck Cancer - Pipeline by A2 Biotherapeutics Inc, 2021
Head And Neck Cancer - Pipeline by Aadi Bioscience Inc, 2021
Head And Neck Cancer - Pipeline by ABBA Therapeutics AG, 2021
Head And Neck Cancer - Pipeline by AbbVie Inc, 2021
Head And Neck Cancer - Pipeline by Abion Inc, 2021
Head And Neck Cancer - Pipeline by Accendatech Co Ltd, 2021
Head And Neck Cancer - Pipeline by Achilles Therapeutics UK Ltd, 2021
Head And Neck Cancer - Pipeline by Actuate Therapeutics Inc, 2021
Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, 2021
Head And Neck Cancer - Pipeline by ADC Therapeutics SA, 2021
Head And Neck Cancer - Pipeline by Adlai Nortye Biopharma Co Ltd, 2021
Head And Neck Cancer - Pipeline by Advanced Accelerator Applications SA, 2021
Head And Neck Cancer - Pipeline by Advaxis Inc, 2021
Head And Neck Cancer - Pipeline by Advenchen Laboratories LLC, 2021
Head And Neck Cancer - Pipeline by Adze Biotechnology Inc, 2021
Head And Neck Cancer - Pipeline by Affimed GmbH, 2021
Head And Neck Cancer - Pipeline by AGC Biologics SpA, 2021
Head And Neck Cancer - Pipeline by Agenus Inc, 2021
Head And Neck Cancer - Pipeline by Akeso Inc, 2021
Head And Neck Cancer - Pipeline by Alkermes Plc, 2021
Head And Neck Cancer - Pipeline by Alligator Bioscience AB, 2021
Head And Neck Cancer - Pipeline by Alphageneron-Pharmaceuticals Inc, 2021
Head And Neck Cancer - Pipeline by Alphamab Oncology, 2021
Head And Neck Cancer - Pipeline by ALX Oncology Holdings Inc, 2021
Head And Neck Cancer - Pipeline by Ambrx Biopharma Inc, 2021
Head And Neck Cancer - Pipeline by amcure GmbH, 2021
Head And Neck Cancer - Pipeline by Amgen Inc, 2021
Head And Neck Cancer - Pipeline by AMI Onco Theranostics LLC, 2021
Head And Neck Cancer - Pipeline by AnBogen Therapeutics, 2021
Head And Neck Cancer - Pipeline by ANP Technologies Inc, 2021
Head And Neck Cancer - Pipeline by Anteris Technologies Ltd, 2021
Head And Neck Cancer - Pipeline by AP Biosciences Inc, 2021
Head And Neck Cancer - Pipeline by Apexigen Inc, 2021
Head And Neck Cancer - Pipeline by Apollomics Inc, 2021
Head And Neck Cancer - Pipeline by Arch Oncology Inc, 2021
Head And Neck Cancer - Pipeline by Arcus Biosciences Inc, 2021
Head And Neck Cancer - Pipeline by Immvira Co Ltd, 2021
Head And Neck Cancer - Pipeline by Imugene Ltd, 2021
Head And Neck Cancer - Pipeline by IMV Inc, 2021
Head And Neck Cancer - Pipeline by Incyte Corp, 2021
Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals Inc, 2021
Head And Neck Cancer - Pipeline by Inhibrx Inc, 2021
Head And Neck Cancer - Pipeline by Innate Pharma SA, 2021
Head And Neck Cancer - Pipeline by InnoMab Pte Ltd, 2021
Head And Neck Cancer - Pipeline by Innovene, 2021
Head And Neck Cancer - Pipeline by Shanghai Jing Ze Biotechnology Co Ltd, 2021
Head And Neck Cancer - Pipeline by Shanghai Junshi Bioscience Co Ltd, 2021
Head And Neck Cancer - Pipeline by Shanghai Miracogen Inc, 2021
Head And Neck Cancer - Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021
Head And Neck Cancer - Pipeline by Shattuck Labs Inc, 2021
Head And Neck Cancer - Pipeline by Shenghe (China) Biopharmaceutical Co Ltd, 2021
Head And Neck Cancer - Pipeline by Shionogi & Co Ltd, 2021
Head And Neck Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, 2021
Head And Neck Cancer - Pipeline by Silverback Therapeutics Inc, 2021
Head And Neck Cancer - Pipeline by Simcha Therapeutics Inc, 2021
Head And Neck Cancer - Pipeline by Sino Biopharmaceutical Ltd, 2021
Head And Neck Cancer - Pipeline by Sirnaomics Inc, 2021
Head And Neck Cancer - Pipeline by Sirona Therapeutics Inc, 2021Head And Neck Cancer - Pipeline by SQZ Biotechnologies

List Of Figures

LIST OF FIGURES

Number of Products under Development for Head And Neck Cancer, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021